Supply of Remdesivir
Department of Health and Social Care (T&T)contractContracts Finder ↗Ref CF-1088300D0O000000rwimUAAcomplete
Estimated value
£17.3m
Awarded value
£17.3m
Awarded 30 Mar 2022
Suppliers
1
Lots
1
1 awarded
Published
07 Oct 2022
Deadline 30 Mar 2022
Description
This contract is call off no. 11 from a EU Framework Agreement for the Supply of Remdesivir.
Scope
- Reference
- CF-1088300D0O000000rwimUAA
- Total value
- £17,334,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Mar 2022 to 06 Jul 2022
- CPV classifications
- 33600000
Submission & procedure
- Submission deadline
- 30 Mar 2022, 10:45 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£17.3m
Award date
30 Mar 2022
Contract start
30 Mar 2022
Contract end
06 Jul 2022
Awarded to
Awarded suppliers· 1 supplier
Awarded 30 Mar 2022 · Contract period 30 Mar 2022 — 06 Jul 2022
Award value
£17.3m
Other contracts from Department of Health and Social Care (T&T)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Gilead Sciences Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Grant Funding - Gilead Science under Grant 25759 | contract | — | 23 Jun 2026 |
| HIV Medicines | contract | — | 07 May 2026 |
| Remdesivir infusion | contract | — | 29 Apr 2026 |
| Biktarvy | contract | — | 28 Apr 2026 |
| Biktarvy | contract | — | 28 Apr 2026 |
| NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives | contract | — | 26 Feb 2026 |
| Antiretroviral Drugs | contract | — | 06 May 2025 |
| NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 | contract | £48.2m | 28 Nov 2024 |
| NHS National Framework for Transition products commencing 1 October 2024 | contract | £1.4m | 17 Oct 2024 |
| NP49124 Hepatitis C Medicines | contract | — | 21 Mar 2024 |